{
    "body": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19171649", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15808842", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15831522", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23532677", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19629520", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11577024", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18622044", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20228172", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19832729", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17317766", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16155104", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15687816", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14704232"
    ], 
    "ideal_answer": [
        "\u03b2-myosin heavy chain, alpha-myosin heavy chain, SR(Ca)ATPase, phospholamban, nucleotide-gated potassium channel 2, KCNE1, HCN2, HCN4, KCND2, KCND3, KCNA4"
    ], 
    "exact_answer": [
        [
            "\u03b2-myosin heavy chain"
        ], 
        [
            "alpha-myosin heavy chain"
        ], 
        [
            "SR(Ca)ATPase"
        ], 
        [
            "phospholamban"
        ], 
        [
            "nucleotide-gated potassium channel 2"
        ], 
        [
            "KCNE1"
        ], 
        [
            "HCN2"
        ], 
        [
            "HCN4"
        ], 
        [
            "KCND2"
        ], 
        [
            "KCND3"
        ], 
        [
            "KCNA4"
        ]
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011988", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046966", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0010861", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D037021", 
        "http://www.uniprot.org/uniprot/THA_PYGAD", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0004887", 
        "http://www.uniprot.org/uniprot/THA_NECMA", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013963", 
        "http://www.uniprot.org/uniprot/THAA_XENLA", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006321", 
        "http://www.uniprot.org/uniprot/THA_LITCT"
    ], 
    "type": "list", 
    "id": "515c4f05298dcd4e51000006", 
    "snippets": [
        {
            "offsetInBeginSection": 547, 
            "offsetInEndSection": 643, 
            "text": "A group of mice was treated with debutyl-dronedarone (DBD), a selective TR\u03b11 inhibitor (AMI-DBD)", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23532677", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1223, 
            "offsetInEndSection": 1435, 
            "text": "Furthermore, AMI resulted in \u03b2-myosin heavy chain overexpression and reduction in the ratio of SR(Ca)ATPase to phospholamban (PLB). The latter further declined in AMI-DBD mainly due to increased expression of PLB", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23532677", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 501, 
            "offsetInEndSection": 774, 
            "text": "We identified that mice expressing the mutant TRalpha1R384C (TRalpha1+m mice) displayed a mild bradycardia, which becomes more pronounced during night activity or on stress and is accompanied by a reduced expression of nucleotide-gated potassium channel 2 mRNA in the heart", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20228172", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 794, 
            "offsetInEndSection": 863, 
            "text": "KCNE1 was four to 10-fold overexpressed in mice deficient in TRalpha1", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1361, 
            "offsetInEndSection": 1542, 
            "text": "The bradycardia and prolonged QT(end) time in hypothyroid states can be explained by altered K(+) channel function due to decreased TRalpha1-dependent repression of KCNE1 expression", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 965, 
            "offsetInEndSection": 1107, 
            "text": "Consistently, TR alpha 1-infected myocytes exhibited larger I(f) current densities along with increased HCN2 and HCN4 mRNA and protein levels.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19629520", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 530, 
            "offsetInEndSection": 649, 
            "text": "T3 stimulation enhanced KCND2 and KCND3 expression and decreased KCNA4 transcription, while KCNIP2 remained unaffected.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 824, 
            "offsetInEndSection": 1010, 
            "text": "TRalpha1 increased I(to), while TRbeta1 significantly reduced I(to) in size, which was associated with TRalpha1-mediated increase and TRbeta1-mediated reduction of KCND2/3 transcription.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1280, 
            "offsetInEndSection": 1474, 
            "text": "While the TRalpha1 aporeceptor enhanced KCND3 transcription, the TRbeta1 aporeceptor suppressed KCND3 expression, with both effects exhibiting ligand-dependent amplification upon T3 stimulation.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19171649", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 791, 
            "offsetInEndSection": 1097, 
            "text": "PE, in the absence of T3, resulted in 5.0 fold increase in TRalpha1 expression in nucleus and 2.0 fold decrease in TRalpha1 expression in cytosol, P<0.05. As a result, a fetal pattern of myosin isoform expression with marked expression of beta-MHC was observed in PE treated vs the untreated cells, P<0.05.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18622044", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1597, 
            "offsetInEndSection": 2002, 
            "text": "PKC alpha overexpression in cardiomyocytes caused marked repression of triiodothyronine (T3)-responsive genes, alpha-myosin heavy chain, and the sarcoplasmic reticulum calcium-activated adenosinetriphosphatase SERCA2. Treatment with T3 for 4 h resulted in significant reductions of PKC alpha in nuclear and cytosolic compartments, and decreased TR alpha1 mRNA and protein, with normalization of phenotype.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16155104", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 444, 
            "offsetInEndSection": 618, 
            "text": "The mechanism of TH and TRalpha1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta-activated kinase (TAK1) and p38", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15831522", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1301, 
            "offsetInEndSection": 1383, 
            "text": "Excised TRalpha(1)+/m hearts showed an increased expression of phospholamban (PLB)", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15808842", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 112, 
            "offsetInEndSection": 290, 
            "text": "administration of dronedarone, an amiodarone-like compound that has been shown to preferentially antagonize thyroid hormone binding to thyroid hormone receptor alpha1 (TRalpha1),", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687816", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 776, 
            "offsetInEndSection": 976, 
            "text": "lpha-Myosin heavy chain (alpha-MHC) decreased in DRON while beta-myosin heavy chain (beta-MHC) and sarcoplasmic reticulum Ca2+ adenosine triphosphatase (ATPase) expression (SERCA) was similar to CONT.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687816", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1094, 
            "offsetInEndSection": 1424, 
            "text": "The activity of TR DNA binding to the transcriptional regulatory region in the alpha-MHC and SR Ca(2+)-ATPase genes and the mRNA and protein expression of alpha-MHC and SR Ca(2+)-ATPase in the heart and plasma 3,3'-triiodothyronine and thyroxine levels were altered in association with changes in the myocardial TR protein levels.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14704232", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1173, 
            "offsetInEndSection": 1441, 
            "text": "addition, TR cotransfection and treatment with the TRbeta1-selective agonist GC-1 suggested different functional coupling of the TR isoforms, TRbeta1 to transcription of beta-MyHC, SERCA, and TRbeta1, and TRalpha1 to alpha-MyHC transcription and increased myocyte size", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11577024", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 233, 
            "text": "OBJECTIVE: The reduced heart rate and prolonged QT(end) duration in mice deficient in thyroid hormone receptor (TR) alpha1 may involve aberrant expression of the K(+) channel alpha-subunit KCNQ1 and its regulatory beta-subunit KCNE1.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19832729", 
            "endSection": "sections.0"
        }
    ]
}